NewAmsterdam Pharma Company N.V. (NAMS)
NASDAQ·Healthcare·Biotechnology
$22.65
-2.87%
Mkt Cap $2.47B
Analyst Ratings
Buy
3
Hold
0
Sell
0
Price Target (12 analysts)
$48.00
Range $45.00 – $51.00
Implied Upside
+111.9%
Consensus $48.00 vs current $22.65